Potential Pulmonary Benefit of Low Pressure Laparoscopic Cholecystectomy in Selected Patients

NCT ID: NCT04670952

Last Updated: 2020-12-23

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Clinical Phase

NA

Total Enrollment

140 participants

Study Classification

INTERVENTIONAL

Study Start Date

2019-06-10

Study Completion Date

2021-12-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Standard Pressure Laparoscopic Cholecystectomy,as the standard for cholecystectomy, can lead to about 15% of pulmonary atelectasis. According to literature, low pressure laparoscopic cholecystectomy is thought to probably decrease cardio-pulmonary related complications and postoperative pain. However, the previous studies have presented controversial results. Our study aim to evaluate the potential pulmonary benefit of low pressure laparoscopic cholecystectomy in elderly or patients accompanied with cardio-pulmonary disorders.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Standard Pressure Laparoscopic Cholecystectomy, SPLC;12-16mmHg,as the standard for cholecystectomy, can lead to about 15% of pulmonary atelectasis.

According to literature, Low Pressure Laparoscopic Cholecystectomy, LPLC;8-10mmHg is thought to probably decrease cardio-pulmonary related complications and postoperative pain. However, most of the existing study have combined population with all age scale, bringing bias to the result. Our study aim to evaluate the potential pulmonary benefit of low pressure laparoscopic cholecystectomy in elderly or patients accompanied with cardio-pulmonary disorders.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Cholecystitis/Cholelithiasis Cholecystitis; Gallstone Polyp Gallbladder

Keywords

Explore important study keywords that can help with search, categorization, and topic discovery.

low pressure; laparoscopic cholecystectomy

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

PREVENTION

Blinding Strategy

DOUBLE

Participants Outcome Assessors
It will be single blinded. Operator, first assistant and data collector could not be blinded. Whereas patients, nurses, data analyzer, and those who have the access to the primary predictor will be blinded.

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Low Pressure Laparoscopic Cholecystectomy

LPLC refers to "Low Pressure Laparoscopic Cholecystectomy". In this arm, the pneumoperitoneum pressure is set as 10mmHg.

Group Type EXPERIMENTAL

Low Pressure Laparoscopic Cholecystectomy

Intervention Type OTHER

Low Pressure Laparoscopic Cholecystectomy (10mmHg) is set as the experimental group.

Standard Pressure Laparoscopic Cholecystectomy

This is taken as the control group. SPLC refers to "Standard Pressure Laparoscopic Cholecystectomy". In this arm, the pneumoperitoneum pressure is set as 14 mmHg.

Group Type OTHER

Standard Pressure Laparoscopic Cholecystectomy

Intervention Type OTHER

Standard Pressure Laparoscopic Cholecystectomy (14mmHg) is set as the control group.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Low Pressure Laparoscopic Cholecystectomy

Low Pressure Laparoscopic Cholecystectomy (10mmHg) is set as the experimental group.

Intervention Type OTHER

Standard Pressure Laparoscopic Cholecystectomy

Standard Pressure Laparoscopic Cholecystectomy (14mmHg) is set as the control group.

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

1. Aged 18-85;
2. Patients receiving laparoscopic cholecystectomy due to benign gallbladder diseases;
3. Older patient or accompanied by cardiopulmonary diseases (age\>60 years, hypertension, Diabetes Mellitus, coronary heart disease, arrhythmia, chronic bronchitis, emphysema, history of heart surgery, history of lung surgery, history of mediastinal surgery, asthma, et al);
4. Aged older than 60, with or without the above diseases;
5. American society of Aneshesiologists (ASA) II or higher;
6. Informed consent acquired.

Exclusion Criteria

1. Having contraindication of laparoscopic operations;
2. History at epigastric surgery. -
Minimum Eligible Age

18 Years

Maximum Eligible Age

85 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Peking Union Medical College Hospital

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Feng Tian

Attending

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Xiaodong He, Doctor

Role: STUDY_DIRECTOR

Peking Union Medical College Hospital

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Peking Union Medical College Hospital

Beijing, Beijing Municipality, China

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

China

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Feng Tian, Doctor

Role: CONTACT

Phone: +86-01069152600

Email: [email protected]

Jun Lu, Doctor

Role: CONTACT

Phone: +86-01069152601

Email: [email protected]

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Hui Xu, Docor

Role: primary

References

Explore related publications, articles, or registry entries linked to this study.

Tian F, Sun X, Yu Y, Zhang N, Hong T, Liang L, Yao B, Song L, Pei C, Wang Y, Lu W, Qu Q, Guo J, Zhang T, He X. Comparison of low-pressure and standard-pressure pneumoperitoneum laparoscopic cholecystectomy in patients with cardiopulmonary comorbidities: a double blinded randomized clinical trial. BMC Surg. 2024 Nov 6;24(1):348. doi: 10.1186/s12893-024-02606-w.

Reference Type DERIVED
PMID: 39506748 (View on PubMed)

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

Feng Tian

Identifier Type: -

Identifier Source: org_study_id